0
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Effects of various controlled ovarian hyperstimulation protocols and surgery on pregnancy outcomes in women with endometriosis

&
Article: 2381504 | Received 03 Mar 2024, Accepted 12 Jul 2024, Published online: 21 Jul 2024

References

  • Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379:e070750. doi: 10.1136/bmj-2022-070750.
  • Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. 2012;39(4):535–549. doi: 10.1016/j.ogc.2012.10.002.
  • Filip L, Duică F, Prădatu A, et al. Endometriosis associated infertility: a critical review and analysis on etiopathogenesis and therapeutic approaches. Medicina (Kaunas). 2020;56(9):460. doi: 10.3390/medicina56090460.
  • Muteshi CM, Ohuma EO, Child T, et al. The effect of endometriosis on live birth rate and other reproductive outcomes in ART cycles: a cohort study. Hum Reprod Open. 2018;2018(4):hoy016. hoy016. doi: 10.1093/hropen/hoy016.
  • Prefumo F, Rossi AC. Endometriosis, endometrioma, and ART results: current understanding and recommended practices. Best Pract Res Clin Obstet Gynaecol. 2018;51:34–40. doi: 10.1016/j.bpobgyn.2018.01.019.
  • Bonavina G, Taylor HS. Endometriosis-associated infertility: from pathophysiology to tailored treatment. Front Endocrinol (Lausanne). 2022;13:1020827. doi: 10.3389/fendo.2022.1020827.
  • Shan J, Li DJ, Wang XQ. Towards a better understanding of endometriosis-related infertility: a review on how endometriosis affects endometrial receptivity. Biomolecules. 2023;13(3):430. doi: 10.3390/biom13030430.
  • Leone Roberti Maggiore U, Chiappa V, Ceccaroni M, et al. Epidemiology of infertility in women with endometriosis. Best Pract Res Clin Obstet Gynaecol. 2024;92:102454. doi: 10.1016/j.bpobgyn.2023.102454.
  • Simopoulou M, Rapani A, Grigoriadis S, et al. Getting to know endometriosis-related infertility better: a review on how endometriosis affects oocyte quality and embryo development. Biomedicines. 2021;9(3):273. doi: 10.3390/biomedicines9030273.
  • Goud PT, Goud AP, Joshi N, et al. Dynamics of nitric oxide, altered follicular microenvironment, and oocyte quality in women with endometriosis. Fertil Steril. 2014;102(1):151–159.e5. doi: 10.1016/j.fertnstert.2014.03.053.
  • Xu B, Guo N, Zhang X-M, et al. Oocyte quality is decreased in women with minimal or mild endometriosis. Sci Rep. 2015;5(1):10779. doi: 10.1038/srep10779.
  • Simón C, Gutiérrez A, Vidal A, et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod. 1994;9(4):725–729. doi: 10.1093/oxfordjournals.humrep.a138578.
  • Kamath MS, et al. Endometriosis and oocyte quality: an analysis of 13 614 donor oocyte recipient and autologous IVF cycles. Hum Reprod Open. 2022;2022(3):hoac025. doi: 10.1093/hropen/hoac025.
  • Zeng C, Lu R, Li X, et al. The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study. J Ovarian Res. 2022;15(1):116. doi: 10.1186/s13048-022-01042-9.
  • Wu Y, Yang R, Lan J, et al. Ovarian endometrioma negatively impacts oocyte quality and quantity but not pregnancy outcomes in women undergoing IVF/ICSI treatment: a retrospective cohort study. Front Endocrinol (Lausanne). 2021;12:739228. doi: 10.3389/fendo.2021.739228.
  • Sanchez AM, Pagliardini L, Cermisoni GC, et al. Does endometriosis influence the embryo quality and/or development? Insights from a large retrospective matched cohort study. Diagnostics (Basel). 2020;10(2):83. doi: 10.3390/diagnostics10020083.
  • Boucher A, Brichant G, Gridelet V, et al. Implantation failure in endometriosis patients: etiopathogenesis. J Clin Med. 2022;11(18):5366. doi: 10.3390/jcm11185366.
  • Marquardt RM, Kim TH, Shin J-H, et al. Progesterone and estrogen signaling in the endometrium: what goes wrong in endometriosis? Int J Mol Sci. 2019;20(15):3822. doi: 10.3390/ijms20153822.
  • Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update. 2019;25(5):564–591. doi: 10.1093/humupd/dmz018.
  • Moberg C, Bourlev V, Ilyasova N, et al. Levels of oestrogen receptor, progesterone receptor and αB-crystallin in eutopic endometrium in relation to pregnancy in women with endometriosis. Hum Fertil (Camb). 2015;18(1):30–37. doi: 10.3109/14647273.2014.922705.
  • Radzinsky VY, Orazov MR, Ivanov II, et al. Implantation failures in women with infertility associated endometriosis. Gynecol Endocrinol. 2019;35(sup1):27–30. doi: 10.1080/09513590.2019.1632089.
  • Wu J, Yang X, Huang J, et al. Fertility and neonatal outcomes of freeze-all vs. fresh embryo transfer in women with advanced endometriosis. Front Endocrinol (Lausanne). 2019;10:770. doi: 10.3389/fendo.2019.00770.
  • Bourdon M, Santulli P, Maignien C, et al. The deferred embryo transfer strategy improves cumulative pregnancy rates in endometriosis-related infertility: a retrospective matched cohort study. PLoS One. 2018;13(4):e0194800. doi: 10.1371/journal.pone.0194800.
  • Zhou L, Wang L, Geng Q, et al. Endometriosis is associated with a lowered cumulative live birth rate: a retrospective matched cohort study including 3071 in vitro fertilization cycles. J Reprod Immunol. 2022;151:103631. doi: 10.1016/j.jri.2022.103631.
  • Huang XD, Sun ZY, Yu Q. Impact of endometriosis on embryo quality and endometrial receptivity in women undergoing assisted reproductive technology. Reprod Biol. 2023;23(2):100733. doi: 10.1016/j.repbio.2023.100733.
  • Pirtea P, de Ziegler D, Ayoubi JM. Endometrial receptivity in adenomyosis and/or endometriosis. Fertil Steril. 2023;119(5):741–745. doi: 10.1016/j.fertnstert.2023.03.004.
  • de Ziegler D, Pirtea P, Carbonnel M, et al. Assisted reproduction in endometriosis. Best Pract Res Clin Endocrinol Metab. 2019;33(1):47–59. doi: 10.1016/j.beem.2018.10.001.
  • Duan X, Li Z, Li M, et al. Analysis of controlled ovarian hyperstimulation protocols in women over 35 years old with poor ovarian response: a real-world study. BMC Pregnancy Childbirth. 2023;23(1):813. doi: 10.1186/s12884-023-06112-4.
  • Beloosesky R, Kol S, Lightman A, et al. Ovarian stimulation in in vitro fertilization with or without the "long" gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome. Fertil Steril. 2000;74(1):166–168. doi: 10.1016/s0015-0282(00)00574-4.
  • Liu S, Xie Y, Li F, et al. Effectiveness of ultra-long protocol on in vitro fertilization/intracytoplasmic sperm injection-embryo transfer outcome in infertile women with endometriosis: a systematic review and meta-analysis of randomized controlled trials. J Obstet Gynaecol Res. 2021;47(4):1232–1242. doi: 10.1111/jog.14630.
  • Cao X, Chang H-y, Xu J-y, et al. The effectiveness of different down-regulating protocols on in vitro fertilization-embryo transfer in endometriosis: a meta-analysis. Reprod Biol Endocrinol. 2020;18(1):16. doi: 10.1186/s12958-020-00571-6.
  • Huirne JA, Lambalk CB. Gonadotropin-releasing-hormone-receptor antagonists. Lancet. 2001;358(9295):1793–1803. doi: 10.1016/s0140-6736(01)06797-6.
  • Pabuccu R, Onalan G, Kaya C. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril. 2007;88(4):832–839. doi: 10.1016/j.fertnstert.2006.12.046.
  • Kolanska K, Cohen J, Bendifallah S, et al. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: gnRH-agonist versus GnRH-antagonist. J Gynecol Obstet Hum Reprod. 2017;46(9):681–686. doi: 10.1016/j.jogoh.2017.09.007.
  • Chen Q, Du S, Lin Y, et al. Controlled ovarian stimulation for endometriosis patients with ultra-long GnRH-agonist or GnRH-antagonist protocols: a retrospective study by propensity score matching. J Obstet Gynaecol Res. 2023;49(5):1366–1374. doi: 10.1111/jog.15570.
  • Drakopoulos P, Rosetti J, Pluchino N, et al. Does the type of GnRH analogue used, affect live birth rates in women with endometriosis undergoing IVF/ICSI treatment, according to the rAFS stage? Gynecol Endocrinol. 2018;34(10):884–889. doi: 10.1080/09513590.2018.1460346.
  • Zhao F, Lan Y, Chen T, et al. Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study. J Ovarian Res. 2020;13(1):23. doi: 10.1186/s13048-020-00622-x.
  • Li X, Zhang X, Cai J, et al. Granulosa cells apoptosis and follicular fluid hormones: comparison of progestin-primed ovarian stimulation versus GnRH antagonist protocols. Gynecol Endocrinol. 2021;37(7):609–613. doi: 10.1080/09513590.2020.1822802.
  • Zhang Y, Xu Y, Wang Y, et al. Comparison of the predictive value of progesterone-related indicators for pregnancy outcomes of women undergoing the short-acting GnRH agonist long protocol: a retrospective study. J Ovarian Res. 2021;14(1):14. doi: 10.1186/s13048-021-00768-2.
  • Guo H, Li J, Shen X, et al. Efficacy of different progestins in women with advanced endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization-a single-center non-inferiority randomized controlled trial. Front Endocrinol (Lausanne). 2020;11:129. doi: 10.3389/fendo.2020.00129.
  • Guo H, Du T, Gao H, et al. The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial. Reprod Health. 2022;19(1):198. doi: 10.1186/s12978-022-01500-z.
  • Alborzi S, Askary E, Keramati P, et al. Assisted reproductive technique outcomes in patients with endometrioma undergoing sclerotherapy vs laparoscopic cystectomy: prospective cross-sectional study. Reprod Med Biol. 2021;20(3):313–320. doi: 10.1002/rmb2.12386.
  • Şükür YE, Özmen B, Yakıştıran B, et al. Endometrioma surgery is associated with increased risk of subsequent assisted reproductive technology cycle cancellation: a retrospective cohort study. J Obstet Gynaecol. 2021;41(2):259–262. doi: 10.1080/01443615.2020.1754366.
  • Bourdon M, Dahan Y, Maignien C, et al. Influence of endometrioma size on ART outcomes. Reprod Biomed Online. 2022;45(6):1237–1246. doi: 10.1016/j.rbmo.2022.08.097.
  • Raos M, Roman H, Seyer-Hansen M, et al. EFFORT study: comparing impact of operation and assisted reproductive technologies on fertility for women with deep infiltrating endometriosis – study protocol for a multicentre randomised trial. BMJ Open. 2022;12(4):e052877. doi: 10.1136/bmjopen-2021-052877.
  • Ekine AA, Fülöp I, Tekse I, et al. The surgical benefit of hysterolaparoscopy in endometriosis-related infertility: a single centre retrospective study with a minimum 2-year follow-up. J Clin Med. 2020;9(2):507. doi: 10.3390/jcm9020507.
  • Ferrier C, Hini JD, Gaillard T, et al. First-line surgery vs first-line ART to manage infertility in women with deep endometriosis without bowel involvement: a multi-centric propensity-score matching comparison. Eur J Obstet Gynecol Reprod Biol. 2023;280:184–190. doi: 10.1016/j.ejogrb.2022.11.013.
  • Maignien C, Santulli P, Bourdon M, et al. Deep infiltrating endometriosis: a previous history of surgery for endometriosis may negatively affect assisted reproductive technology outcomes. Reprod Sci. 2020;27(2):545–554. doi: 10.1007/s43032-019-00052-1.
  • Ban Frangež H, Vrtacnik Bokal E, Štimpfel M, et al. Reproductive outcomes after laparoscopic surgery in infertile women affected by ovarian endometriomas, with or without in vitro fertilisation: results from the SAFE (surgery and ART for endometriomas) trial. J Obstet Gynaecol. 2022;42(5):1293–1300. doi: 10.1080/01443615.2021.1959536.
  • Hamdan M, Dunselman G, Li TC, et al. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015;21(6):809–825. doi: 10.1093/humupd/dmv035.
  • Daniilidis A, Angioni S, Di Michele S, et al. Deep endometriosis and infertility: what is the impact of surgery? J Clin Med. 2022;11(22):6727. doi: 10.3390/jcm11226727.
  • Bourdon M, Peigné M, Maignien C, et al. Impact of endometriosis surgery on in vitro fertilization/intracytoplasmic sperm injection outcomes: a systematic review and meta-analysis. Reprod Sci. 2024;31(6):1431–1455. doi: 10.1007/s43032-023-01421-7.
  • Vannuccini S, Clemenza S, Rossi M, et al. Hormonal treatments for endometriosis: the endocrine background. Rev Endocr Metab Disord. 2022;23(3):333–355. doi: 10.1007/s11154-021-09666-w.
  • Tian Y, Zhang L, Qi D, et al. Efficacy of long-term pituitary down-regulation pretreatment prior to in vitro fertilization in infertile patients with endometriosis: a meta-analysis. J Gynecol Obstet Hum Reprod. 2023;52(3):102541. doi: 10.1016/j.jogoh.2023.102541.
  • Buggio L, Dridi D, Barbara G, et al. Novel pharmacological therapies for the treatment of endometriosis. Expert Rev Clin Pharmacol. 2022;15(9):1039–1052. doi: 10.1080/17512433.2022.2117155.
  • Venetis CA, Storr A, Chua SJ, et al. What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis. Hum Reprod Update. 2023;29(3):307–326. doi: 10.1093/humupd/dmac040.
  • Ferrero S, Gazzo I, Crosa M, et al. Impact of surgery for endometriosis on the outcomes of in vitro fertilization. Best Pract Res Clin Obstet Gynaecol. 2024;95:102496. doi: 10.1016/j.bpobgyn.2024.102496.